12-55551647-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005494.2(OR6C4):c.421C>A(p.Gln141Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,613,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005494.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6C4 | NM_001005494.2 | c.421C>A | p.Gln141Lys | missense_variant | 2/2 | ENST00000641569.1 | NP_001005494.1 | |
OR6C4 | NM_001385975.1 | c.421C>A | p.Gln141Lys | missense_variant | 2/2 | NP_001372904.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6C4 | ENST00000641569.1 | c.421C>A | p.Gln141Lys | missense_variant | 2/2 | NM_001005494.2 | ENSP00000493181.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000878 AC: 22AN: 250622Hom.: 0 AF XY: 0.0000812 AC XY: 11AN XY: 135408
GnomAD4 exome AF: 0.000281 AC: 411AN: 1461698Hom.: 0 Cov.: 33 AF XY: 0.000268 AC XY: 195AN XY: 727154
GnomAD4 genome AF: 0.000112 AC: 17AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.421C>A (p.Q141K) alteration is located in exon 1 (coding exon 1) of the OR6C4 gene. This alteration results from a C to A substitution at nucleotide position 421, causing the glutamine (Q) at amino acid position 141 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at